Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Contec, Inc. AcquiresMilliken Anticon® Products Business

By Pharmaceutical Processing | July 15, 2009

Spartanburg-based Contec, Inc. has announced an agreementto purchase the Anticon® Products Wiping Cloth business from Milliken & Company, alsobased in Spartanburg. Contec is a global manufacturer and supplier of pre-saturated anddry wipes, mops, and specialty cleaning supplies for cleanrooms and controlled environments inmicroelectronics, life sciences, aerospace, and automotive markets. Contec has manufacturingfacilities in Spartanburg and Suzhou, China. Contec CEO Jack McBride states that “As long as I can remember Milliken has been a technologicalleader in textiles for critical industrial applications. The current state of the economy has madeconsolidation a necessity in our industry so this step makes sense for both companies. Contec isexcited about working together with Milliken to bring their proprietary technology to a broaderglobal market. The Anticon® brand is synonymous with superior performance and value. Contechas a track record of taking great technology platforms such as the Anticon line and growing theminto significant businesses through superior applications engineering and world-class manufacturing.Our team believes we can expand the global market for Anticon products and keep as manyjobs in the upstate as possible. We view this as a long-term partnership with a technological industryleader.” “During a 6-month transition period, most Anticon® products will continue to be made in their currentlocation,” says McBride. “Customers can be assured of a smooth transition and a continuationof the quality manufacturing they have come to expect from Milliken’s Anticon brand.”

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards